Biotalys

Biotalys R&D per Employee

The R&D Spending per Employee of Biotalys (BTLS.BR) as of Nov 4, 2026 is 179,351.35 EUR. In the previous year, R&D Spending per Employee was 148,837.84 EUR — a change of 20.50% (higher).

R&D per Employee

179,351.35EUR

YoY

20.50%

Last updated:

R&D Spending per Employee of Biotalys is 2025 179,351.35 EUR. R&D Spending per Employee of Biotalys was 2024 148,837.84 EUR. It decreases by 20.50% higher compared to the previous year.

The Biotalys R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2019
106,094.59 EUR
Jan 1, 2020
155,243.24 EUR
Jan 1, 2021
187,567.57 EUR
Jan 1, 2022
254,229.73 EUR
Jan 1, 2023
225,202.70 EUR
Jan 1, 2024
148,837.84 EUR
Jan 1, 2025
179,351.35 EUR
The Biotalys R&D per Employee history
YEARR&D per EmployeeYoY
179,351.35EUR+20.50%
148,837.84EUR-33.91%
225,202.70EUR-11.42%
254,229.73EUR+35.54%
187,567.57EUR+20.82%
155,243.24EUR+46.33%
106,094.59EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biotalys Stock analysis

What does Biotalys do? Biotalys NV develops sustainable crop protection products, including AGROBODY Foundry, which combines active ingredients with Agrobodies as formulation agents. The company offers protein-based biocontrol solutions targeting crop pests and diseases, with a product pipeline called EvocaTM addressing key agricultural threats. Biotalys provides tools to prevent crop loss, extend post-harvest protection, and reduce food waste through its BioFungicides, BioInsecticides, and BioBactericides product lines. The company generates revenue by selling its crop protection products to agricultural stakeholders, including farmers and agribusinesses seeking sustainable pest management solutions. AGROBODY Foundry and EvocaTM are key products driving sales, while BioFungicides, BioInsecticides, and BioBactericides form the core of its product portfolio. Biotalys focuses on delivering biocontrol solutions that tackle a wide range of crop pests and diseases, appealing to environmentally conscious agricultural sectors. Biotalys' business model centers on developing and commercializing bio-based crop protection technologies. Its product pipeline, including EvocaTM and the three biocontrol categories, targets the growing market for sustainable agricultural practices. The company monetizes its technology through direct sales of its branded products to end-users in the agricultural industry, emphasizing eco-friendly alternatives to conventional pesticides. Biotalys is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biotalys stock

R&D Spending per Employee of Biotalys is 179,351.35 EUR in 2025.

R&D Spending per Employee of Biotalys changed from 148,837.84 EUR to 179,351.35 EUR, representing a 20.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Biotalys since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Biotalys historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Biotalys

All Key Metrics — Biotalys